Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Morales Salinas

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Revista Espanola De Cardiologia (English Ed.)|July 1, 2019
Are There Gaps in the Evidence on the Treatment of Mild Hypertension in Patients With Low Cardiovascular Risk?Alberto Morales-Salinas
Revista Espanola De Cardiologia (English Ed.)|December 3, 2014
Optimal medical treatment: is it the worst option in multivessel coronary disease?Alberto Morales Salinas
The Lancet. Neurology|July 9, 2010
Atenolol in uncomplicated hypertension: time for changesAlberto Morales Salinas
Revista Espanola De Cardiologia|June 24, 2008
[The obesity paradox or vulnerability of the underweight]Alberto Morales Salinas
Revista Espanola De Cardiologia|March 17, 2006
[Concerning World Heart Day]Alberto Morales Salinas, Antonio Coca
Medicina Clinica|May 22, 2009
[Obesity, physical activity and cardiovascular risk: ergoanthropometric classification, pharmacological variables, biomarkers and "obesity paradox"]Alberto Morales Salinas, Antonio Coca
European Heart Journal|March 16, 2019
Concerning the degradation of β-blocker use in the 2018 ESC/ESH hypertension guidelinesAlberto Morales-Salinas, Richard Kones
Mayo Clinic Proceedings|October 3, 2009
Ergo-anthropometric assessmentAlberto Morales Salinas, Antonio Coca
Revista Espanola De Cardiologia|November 13, 2007
[Comment on "Comparison of the REGICOR and SCORE function charts..."]Alberto Morales Salinas, Carlos Martínez Espinosa
Lancet (London, England)|December 8, 2018
Confronting the most challenging risk factor: non-adherenceRichard Kones, Umme Rumana, Alberto Morales-Salinas
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Revista Espanola De Cardiologia (English Ed.)|July 1, 2019
Are There Gaps in the Evidence on the Treatment of Mild Hypertension in Patients With Low Cardiovascular Risk?Alberto Morales-Salinas
Revista Espanola De Cardiologia (English Ed.)|December 3, 2014
Optimal medical treatment: is it the worst option in multivessel coronary disease?Alberto Morales Salinas
The Lancet. Neurology|July 9, 2010
Atenolol in uncomplicated hypertension: time for changesAlberto Morales Salinas
Revista Espanola De Cardiologia|June 24, 2008
[The obesity paradox or vulnerability of the underweight]Alberto Morales Salinas
Revista Espanola De Cardiologia|March 17, 2006
[Concerning World Heart Day]Alberto Morales Salinas, Antonio Coca
Medicina Clinica|May 22, 2009
[Obesity, physical activity and cardiovascular risk: ergoanthropometric classification, pharmacological variables, biomarkers and "obesity paradox"]Alberto Morales Salinas, Antonio Coca
European Heart Journal|March 16, 2019
Concerning the degradation of β-blocker use in the 2018 ESC/ESH hypertension guidelinesAlberto Morales-Salinas, Richard Kones
Mayo Clinic Proceedings|October 3, 2009
Ergo-anthropometric assessmentAlberto Morales Salinas, Antonio Coca
Revista Espanola De Cardiologia|November 13, 2007
[Comment on "Comparison of the REGICOR and SCORE function charts..."]Alberto Morales Salinas, Carlos Martínez Espinosa
Lancet (London, England)|December 8, 2018
Confronting the most challenging risk factor: non-adherenceRichard Kones, Umme Rumana, Alberto Morales-Salinas
Pageof 3